ALH
Cycle Management

PCT & Recovery Protocols

Understanding Post Cycle Therapy, Blast & Cruise methodology, and critical age-specific considerations for safe and effective hormone management.

Post Cycle Therapy (PCT)
Restart natural testosterone production after steroid cycle
Duration: 4-6 weeksStart: Start 1-2 weeks after last injection of long-ester steroid

PCT Compounds

Nolvadex (Tamoxifen)
40mg/day weeks 1-2, then 20mg/day weeks 3-6

SERM that blocks estrogen in pituitary, stimulating LH/FSH release

Clomid (Clomiphene)
50mg/day weeks 1-2, then 25mg/day weeks 3-6

Alternative or additional SERM for HPTA restart

Blast and Cruise (B&C)
Avoid hormonal crash by never coming off steroids
Permanent commitment to exogenous hormones
Blast Phase
8-16 weeks

High-dose supraphysiological cycle for muscle growth

500mg Testosterone E + 400mg Masteron per week

Cruise Phase
As long or longer than blast

TRT-level testosterone to maintain health and gains

125-150mg Testosterone E per week

Advantages

  • No hormonal crash
  • Superior muscle retention
  • More stable hormonal state
  • Better quality of life between cycles

Disadvantages

  • Permanently shut down HPTA
  • Permanent infertility without HCG
  • Constant cardiovascular strain
  • Lifelong commitment
  • Requires diligent health monitoring
Age-Specific Considerations (46-Year-Old Male)
Critical health factors that dramatically increase risk for users over 40
Cardiovascular Health
Very High Risk
  • 20+ years more wear and tear on cardiovascular system
  • Higher likelihood of undiagnosed plaque buildup
  • Steroids worsen cholesterol (lower HDL, raise LDL)
  • Blood pressure elevation from water retention
  • Thickened blood from increased RBC count
  • Dramatically increased risk of heart attack, stroke, blood clots
Prostate Health
High Risk
  • DHT conversion accelerates prostate growth
  • Higher baseline risk of BPH at 46
  • Testosterone can fuel undiagnosed prostate cancer
  • Symptoms: frequent urination, weak stream, difficulty urinating
HPTA Recovery
Very High Risk
  • Slower and less certain recovery than younger users
  • Higher risk of permanent shutdown
  • May require TRT for life after cycle
  • Natural testosterone already declining with age

Latest Protocol Research

Peer-reviewed findings, automatically curated and reviewed

UpdateHigh Confidence
Lack of objective evidence for PCT effectiveness

Despite its common use, there is currently no objective scientific evidence confirming the effectiveness of Post-Cycle Therapy (PCT) in mitigating AAS withdrawal symptoms or expediting testicular recovery.

Added about 13 hours ago1 source
New DataMedium Confidence
PCT associated with reduced AAS withdrawal symptoms

A survey found that men who use anabolic-androgenic steroids (AAS) report fewer withdrawal symptoms when self-administering Post-Cycle Therapy (PCT), which typically includes hCG and SERMs.

Added about 13 hours ago1 source
MechanismHigh Confidence
Common PCT compounds and their intended actions

PCT commonly uses hCG and SERMs, which are intended to stimulate testicular function to aid recovery from AAS-induced hypogonadism and reduce withdrawal symptoms.

Added about 13 hours ago1 source
MechanismHigh Confidence
PCT compounds (hCG, SERMs) stimulate testicular function

PCT commonly uses hCG and SERMs, which are known to potently stimulate testicular function, aiming to help recovery from AAS-induced hypogonadism.

Added about 13 hours ago1 source

All findings are sourced from peer-reviewed literature and reviewed before publication.

Related Research

Continue exploring related topics and protocols